The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what we do have a studies where we look at labeled tracers and that's what shows that in a random sampling Nash people you have a seventy-five percent decrease in able B secretion it doesn't matter what the april-b in the blood is you'd like to know why it's higher but you know that it's not because it's coming out of it's not secure and higher
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.